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ABSTRACT
Phytic acid (myo-inositol hexaphosphate) has gained much attention among researchers for its therapeutic value. This review focuses on 
pharmacological activities of phytic acid, which have been demonstrated by pre-clinical studies. Anti-carcinogenic, antioxidant, antidiabetic, 
hypolipidemic, anti-angiogenic, and immunomodulation are the most extensively studied pharmacological activities of phytic acid. In addition to 
these, phytic acid and its derivatives also possess enzyme inhibitory activities against few key enzymes such as 5-alpha reductase, aldose reductase, 
cyclooxygenase, lipase, matrix metalloproteinase-2 & 9, pepsin, polyphenol oxidase, protease, β-secretase, tyrosinase, and xanthine oxidase were 
emphasized. The profound pharmacological activities of phytic acid have proven to be a good therapeutic agent and could be employed in preventing 
as well as treating such diseases.
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INTRODUCTION
Phytic acid is chemical known as myo-inositol hexaphosphate, which is 
abundant in nature and especially in plants it accounts for 1–5% weight 
of edible cereals, legumes, nuts, oil seeds, and tubers [1-3]. The process 
of synthesizing phytic acid is metabolically expensive, which requires 
six adenosine triphosphate molecules for phosphorylation of each 
phytic acid molecule [4]. An average intake of phytate by humans on 
vegetarian diets is about 2000–2600 mg/day [5]. It is readily absorbed 
in the gastrointestinal (GI) tract and then enters the bloodstream [6]. It 
is also physiologically present in the human large intestine [7].
Phytic acid is a unique negatively charged molecule in a wide pH range 
and having 12 replaceable protons in it [8]. These characteristic chemical 
natures allow the formation of metal complexes with polyvalent metals 
especially with divalent and trivalent [9]. Phytases are the only enzymes, 
which capable of hydrolyzing phytic acid into myo-inositol and inositol 
phosphates [1]. Phytic acid has been well known as anti-nutrient agent 
in the past. Recently, phytic acid has been extensively studied due to 
its numerous biological activities; therefore, it is worthwhile to review 
recent findings on phytic acid and its pharmacological activities. The 
present review, we describe the recent therapeutic potential of phytic 
acid as a promising pharmaceutical agent.
PHARMACOLOGICAL ACTIVITIES OF PHYTIC ACID
Few important pharmacological activities of phytic acid have 
been shown in Fig. 1 wherein, all these publications exemplify the 
numerous pharmaceutical studies and deliberately confirmed the 
potential therapeutic value of the phytic acid against various diseases. 
Furthermore, antineoplastic/anticarcinogenic activity of phytic acid has 
more number of studies/publications, which is followed by antioxidant 
activity and so on (Fig. 1).
Antibacterial activity of phytic acid
Phytic acid is the main storage form of phosphorus in many plant 
tissues. Recently, food-grade phosphate (including phytic acid) has 
gained importance among researchers, due to its usefulness as a food 
additive in a wide variety of meat products. A number of researchers 
have reported that phosphates shown to exhibit antimicrobial 
activities, although it has never been classified as an antimicrobial 
agent. Sodium phytate (sodium salt of phytic acid) has been reported to 
inhibit Escherichia coli growth in raw or cooked meats including beef, 
chicken, and pork [10]. In other study, phytic acid from rice bran has 
been reported to inhibit the growth of both Salmonella typhimurium 
and E. coli [11].
Antidiabetic activity of phytic acid
Yoon et al. [12] reported that phytate-enriched diets result in low 
blood glucose (glycemia) levels in humans. Later two reports shown 
that phytate regulates insulin secretion through inhibiting the serine/
threonine-specific protein phosphatase activity, which, in turn, opens 
intracellular calcium channels required for insulin release [13,14]. 
Kuppusamy et al. [15] reported that phytic acid has been shown to 
exhibit both α-glucosidase and α-amylase inhibition in dose-dependent 
manner (in vitro) and also shown to possess antidiabetic activity against 
streptozotocin-nicotinamide induced diabetes (type 2) in rats. In other 
study, phytic acid extracted from Kenyan local vegetables and grains have 
been shown to possess both α-glucosidase and α-amylase inhibition [16].
Anti-inflammatory activity of phytic acid
Recent investigations suggest that bioactive natural dietary products 
play a key role in the alleviation and control of inflammation-related 
diseases [17,18]. Phytic acid has been reported to exhibit anti-
inflammatory activity against carrageen induced paw edema in 
experimental rats [19].
Antineoplastic/Anticarcinogenic activity of phytic acid
Phytic acid has been shown to exhibit anticarcinogenic activity 
on a wide variety of tumors [20,21], which includes Barrett’s 
adenocarcinoma  [22], breast cancer [23], colon cancer [24,25], 
glioblastoma [26], laryngeal carcinoma [27], oral cavity squamous cell 
carcinoma [28], pancreatic cancer [29], prostate cancer [30], and skin 
cancer [31]. Key mechanism actions of phytic acid against tumors have 
been shown in Fig. 2.
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Antiviral activity of phytic acid
Phytic acid has been reported to inhibit the proliferation of human 
immunodeficiency virus (HIV) under in vitro condition [38]. In other 
study, anti-HIV1 activity of both myo-inositol hexaphosporic acid (IP6) 
and myo-inositol hexasulfate (IS6) has been reported in detail [39].
Cariostatic activity of phytic acid
Sodium phytate (sodium salt of phytic acid) has been shown to 
possess cariostatic activity using in vivo studies [40-42]. Kaufman 
and Kleinberg [43] reported that the cariostatic action of phytic acid 
and its derivatives have been attributed mainly, due to its ability to 
lower solubilizes of calcium, fluoride, and phosphate as they major 
components of tooth enamel. Phytic acid has been tested in toothpaste 
as a tool for preventing tooth plaque formation [44].
Hemolytic activity of phytic acid
Hemolytic activity of any substances or compounds is a measure of 
general cytotoxicity toward normal healthy cells. Phytic acid has not 
shown any hemolysis at ≥1 mM concentration level, however significantly 
increases the percentage of annexin V-binding erythrocytes  [45].
Hypoallergenic activity of phytic acid
Peanut allergy is one of the most common food allergies among the 
schoolchildren in United States of America (USA) and United Kingdom. 
Phytic acid has been shown to possess hypoallergenic activity against 
peanut allergens [46].
Hypolipidemic activity of phytic acid
Katayama [47] reported the hypolipidemic activity of phytic acid in 
rat model. Lee et al. [48] reported that dietary phytic acid reduces 
serum and hepatic lipid levels in aged ICR mice feed with high 
cholesterol diet. In other study, phytic acid has been reported to possess 
antihyperlipidemic activity against high fat-induced mice model [49].
Immunomodulatory activity of phytic acid
An immunomodulatory agent is a substance that may be an 
immunostimulator or an immunosuppressant based on its effect on the 
immune system. Phytic acid has been shown to possess immunomodulatory 
activity against bacterial lipopolysaccharide-induced human mononuclear 
cells [50].
Neuroprotective activity of phytic acid
Alterations in antioxidant status in nervous tissue have been implicated 
in pathologies of neurodegenerative disorders such as amyotrophic 
lateral sclerosis, Alzheimer’s disease, and Parkinson’s disease. Phytic 
acid has been shown to possess neuroprotective activity against 
Parkinson’s disease [51,52].
Phytic acid against renal stone formation
Renal stone disease is an ailment afflicting human beings for many 
centuries. A majority of renal stones are calcium stones, which account 
approximately 80% of all of these stones. Phytic acid has been reported 
to inhibit the calcium oxalate crystal formation, which, in turn, prevents 
renal stone formation [53,54].
ENZYME INHIBITORY ACTIVITIES OF PHYTIC ACID AND ITS 
DERIVATIVES
Few reported enzyme inhibitory activities of phytic acid and its derivatives 
have been shown in Fig. 3 and discussed below in detail. Recently, phytic 
acid has been reported to inhibit the enzymes such as cyclooxygenase-2 
(COX-2), human neutrophil elastase, lipoxygenase, microsomal 
prostaglandin E synthase-2, and tyrosinase using in silico approach [55].
Phytic acid as 5-alpha-reductase inhibitor
5-alpha-reductase is an enzyme which catalyzes conversion of 
testosterone to dihydrotestosterone. In men elevated enzyme activity is 
associated with benign prostatic hypertrophy and premature baldness. 
Fig. 1: Represents various pharmacological activities of phytic 
acid
Fig. 2: Represents molecular targets of phytic acid 
(cyclooxygenase-2; matrix metalloproteinase; nuclear factor 
kappa B; B-cell lymphoma-extra large; vascular endothelial 
growth factor and WAF1/Cip1-wild type activating fragment 1/
cyclin-dependent kinase inhibitory protein 1)
Antioxidant activity of phytic acid
Phytic acid has been reported to inhibit the hydroxyl radical 
formation [32,33] and lipid peroxidation activities [1,34]. In other 
study, phytic acid extracted from Kenyan local vegetables and grains 
have been shown to possess 2,2-diphenylpicrylhydrazyl radical 
scavenging activity [16]. Furthermore, phytic acid has been reported to 
exhibit antioxidant activity [35].
Antiplatelet and anti-angiogenic activity of phytic acid
Vucenik et al. [36] reported that phytic acid inhibits human 
platelet aggregation in a dose-dependent manner under in vitro 
condition. 5 years later, phytic acid has been reported to possess 
anti-angiogenic activity against both in vitro and in vivo induced 
angiogenesis [37].
Antiulcer activity of phytic acid
Ulcer is a common GI disorder. Ulcers are lesions on the srfuace of 
skin or a mucous membrane clinically characterized by a superficial 
loss of tissue. Phytic acid has been reported to possess antiulcer 
activity against ibuprofen, ethanol, and cold stress-induced ulcers in 
experimental rats [19].
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Phytic acid has been reported to inhibit the 5-alpha-reductase (type 2) 
activity using in silico study, which could prevent prostate cancer and 
hair fall [56].
Phytic acid derivative (PP-56) as aldose reductase inhibitor
Aldose reductase is the key regulatory enzyme in the polyol pathway, 
which catalyzes glucose to sorbitol. Elevated enzyme has been implicated 
in the development of diabetic retinopathy, leading cause of blindness. 
Phytic acid derivative, namely D-myo-inositol 1,2,6-trisphosphate (PP-
56) has been reported to modulate the aldose reductase activity against 
streptozotocin-induced diabetic rats, which could prevent diabetic 
cataract formation [57].
Phytic acid as COX-2 inhibitor
COX is the key regulatory enzyme which catalyzes the conversion of 
arachidonic acid to prostaglandins, where cyclooxygenase-2 is mainly an 
inflammatory, inducible enzyme. Phytic acid has been reported to suppress 
the COX-2 expression in azoxymethane-induced colon cancer cells [58].
Myo-inositol phosphate ester (hydrolyzed product of phytic acid) 
as lipase inhibitor
Lipase is an enzyme which catalyzes the hydrolysis of fats. Elevated 
enzyme activity is associated with inflammatory or neoplastic disease 
of the pancreas. Myo-inositol phosphate ester has been reported to 
inhibit the lipase activity [59].
Phytic acid as matrix metalloproteinase-2 & 9 (MMP-2 & 9) 
inhibitor
MMP’s are a group of zinc-dependent endopeptidase which capable 
of degrading extracellular matrix and are involved in remodelling and 
turnover of dermis [18]. Phytic acid has been reported to modulate 
the MMP-2 gene expression in colon cancer cells [60]. In other study, 
phytic acid has been reported to modulate both the MMP-2 and 9 gene 
expressions against phorbol-12-myristate 13-acetate stimulated colon 
cancer cells [61].
Phytic acid as pepsin inhibitor
Pepsin is a digestive enzyme which capable of degrading food proteins 
into peptides. Pepsin is one of the main causes of mucosal damage 
during laryngopharyngeal reflux. Phytic acid has been reported to 
inhibit the pepsin activity [62].
Phytic acid as polyphenol oxidase (PPO) inhibitor
PPO is copper-containing enzyme having both catecholase and cresolase 
activity. It plays defence role against pathogens and responsible for 
browning reactions. Phytic acid has been reported to inhibit the PPO 
activity, which could prevent browning of apple [63].
Phytic acid as protease inhibitor
Protease is a digestive enzyme, which hydrolysis protein into shorter 
fragments. It occurs in all organisms from prokaryotes to eukaryotes 
to viruses. Phytic acid has been reported to inhibit the protease activity 
in fish [64].
Phytic acid as β-Secretase (BACE-1) inhibitor
BACE-1 is a rate-limiting enzyme involved in production and deposition 
of amyloid- β-peptide (Aβ). It is now emerging as marker enzyme for 
the treatment of Alzheimer’s disease. Phytic acid has been reported to 
inhibit the BACE-1 activity, which could prevent Aβ accumulation [65].
Phytic acid as tyrosinase inhibitor
Tyrosinase is the main regulatory enzyme in melanogenesis process 
particularly in the first two steps such as (i) tyrosine hydroxylation to 
3, 4-dihydroxyphenylalanine (DOPA) and (ii) the oxidation of DOPA 
to dopaquinone. Graf et al. [4] have reported phytic acid, as inhibitor 
of mushroom tyrosinase. In other study, phytic acid containing 
formulation (Amelan M) has been shown to reduce pigmentation in 
melasma patients  [66].
Phytic acid as xanthine oxidase (XO) inhibitor
XO is the key regulatory enzyme in purine metabolism. It catalyzes 
the oxidation of hypoxanthine to xanthine and then to uric acid. Phytic 
acid has been reported to inhibit the XO activity which could prevent 
gout  [67].
APPLICATIONS OF PHYTIC ACID
Phytic acid has been reported for five major applications (Fig. 4) such as 
adsorption and corrosion inhibition, cosmetic, dental care, industrial, 
and medical applications [68].
Among these applications, food industry applications of phytic acid have 
been reported as predominant one, where it has been added to alcoholic 
beverages, bread, canned seafoods, cheese, fish meal pastes, fruits, juices, 
meats, miso, noodles, soy sauce, and vegetables to prevent colour and as well 
as to prolong shelf life of products. In 1997, Food and Drug Administration 
of the USA regarded sodium phytate as generally recognized as safe 
status for using the same as preservative in baked foodstuffs [1]. Second 
medical applications of phytic acid have been gaining importance among 
researchers, due to its potential therapeutic value [68,69].
CONCLUSION
Phytic acid has shown a number of pharmacological activities such 
as antibacterial, antidiabetic, anti-inflammatory, anticarcinogenic, 
antioxidant, anti-angiogenic, antiulcer, antiviral, hypoallergenic, 
hypolipidemic, immunomodulation, and neuroprotection. In addition 
to these, phytic acid and its derivatives also posses enzyme inhibitory 
activities against few key enzymes such as 5-alpha-reductase (type-2), 
aldose reductase, cyclooxygenase (type-2), lipase, MMP-2 and 9, pepsin, 
PPO, protease, BACE-1 (type-1), tyrosinase, and XO. The profound 
pharmacological properties have paved way for various applications 
Fig. 3: Represents the enzyme inhibitory activities of phytic acid 
and its derivatives
Fig. 4: Represents various applications of phytic acid
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of phytic acid. Encouraging pre-clinical studies suggest that phytic acid 
as a promising pharmaceutical agent for prevention and treatment of 
various diseases; however, more controlled clinical trials are required 
to demonstrate its novel therapeutic potential.
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